David S. Blatteis is a member of the firm’s Management Committee and Co-Chair of its Business Law Group. He concentrates his practice in the areas of business law, pharmaceutical, medical device, and healthcare.
David understands the unique business and complex legal concerns of pharmaceutical companies and service providers in the pharmaceutical industry.
He represents pharmaceutical manufacturers, medical device companies, healthcare service organizations and molecular diagnostic companies in connection with a wide range of commercial transactions including mergers and acquisitions, corporate partnerships, joint ventures and other strategic alliances. His clients manufacture, market, promote, advertise and sell pharmaceutical products as well as provide technology, regulatory and compliance and promotional solutions to the healthcare industry. For these clients, he drafts and negotiates manufacturing, supply and development, license, distribution, co-promote and risk-share agreements, customer and vendor contracts, major outsourced sales team, promotional, media, advertising, technology, and service arrangements.
Articles in the National Law Review database by David S. Blatteis